Related Experiment Video
Updated: Nov 29, 2025

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer
Zhenkun Ma1, Ye Gao2, Wei Liu1
1Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China.
Abstract:
CD82 acts as a tumor suppressor in a series of steps in malignant progression. Here, we identified a novel function of CD82 on posttranslational regulating E-cadherin in prostate cancer. In our study, the declined expression of CD82 was verified in prostate cancer tissues and cell lines compared with normal tissue and cell lines. Functionally, CD82 inhibited cell migration and E-cadherin cleavage from the cell membrane in prostate cancer cell. Further study proved that a disintegrin and metalloproteinase ADAM17 as an executor of E-cadherin cleavage mediated the inhibitory regulation of CD82 in E-cadherin shedding in prostate cancer. Specifically, CD82 interacted with ADAM17 and inhibited its metalloprotease activity, which led to the descent of E-cadherin shedding. These results show a nuanced but important role of CD82 in nontranscriptional regulation of E-cadherin, which may help to understand the intricate regulation of dysfunctional adhesion molecule in cancer progression.
Insights
CD82 suppresses tumors by regulating E-cadherin. This study shows CD82 inhibits E-cadherin shedding by interacting with ADAM17, offering new insights into prostate cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- CD82 functions as a tumor suppressor in cancer progression.
- E-cadherin is a critical adhesion molecule often dysregulated in cancer.
Purpose of the Study:
- To investigate the novel role of CD82 in the post-translational regulation of E-cadherin in prostate cancer.
- To elucidate the mechanism by which CD82 influences E-cadherin cleavage and cell migration.
Main Methods:
- Quantitative analysis of CD82 expression in prostate cancer tissues and cell lines.
- Functional assays to assess cell migration and E-cadherin shedding.
- Co-immunoprecipitation and enzyme activity assays to study CD82-ADAM17 interaction.
Main Results:
- CD82 expression is decreased in prostate cancer tissues and cells.
- CD82 inhibits prostate cancer cell migration and E-cadherin shedding.
- CD82 directly interacts with ADAM17, inhibiting its metalloprotease activity and subsequent E-cadherin cleavage.
Conclusions:
- CD82 plays a crucial role in the non-transcriptional regulation of E-cadherin in prostate cancer.
- The CD82-ADAM17 interaction offers a potential therapeutic target for modulating E-cadherin function and inhibiting cancer progression.
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Cancer Cell Migration through Invadopodia
Canonical Wnt Signaling Pathway
Abnormal Proliferation
Structure of Cadherins

